Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1976;21(1):1-30.

Edward T. Tyler Prize Oration: LH-releasing hormone and its analogues: recent basic and clinical investigations

  • PMID: 8392
Review

Edward T. Tyler Prize Oration: LH-releasing hormone and its analogues: recent basic and clinical investigations

A V Schally et al. Int J Fertil. 1976.

Abstract

PIP: Literature on luteinizing hormone-releasing hormone (LH-RH) and its analogues is reviewed. LH-RH, which stimulates the release of both luteinizing hormone (LH) and follicle stimulating hormone (FSH), is active in numerous species. It has been postulated that the release and synthesis of FSH and LH is mediated by an interaction between sex steroids and hypothalamic LH-RH. Administration of antiserum to LH-RH has been shown to block the preovulatory LH surge and ovulation in laboratory animals, which suggests an immunological approach to fertility control. It appears that LH-RH is rapidly broken down by dispersed liver, anterior pituitary, and kidney cells. Cyclic AMP has been shown to act as a mediator of LH-RH and FSH release. Although LH-RH has potential diagnostic value, its effectiveness in differentiating various types of hypogonadism is not clearly established. Generally, sex steroids diminsh the responses to LH-RH, though estrogens have both a stimulatory and inhibitory effect. Glucocorticoids have been shown to suppress the LH response to LH-RH. LH-RH has been effective in inducing ovulation in anovulatory women, and in treating men with hypogonadotropic hypogonadism. Stimulatory and inhibitory analogues of LH-RH and their clinical application are reviewed.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances